“Searching for factors that can protect pancreatic beta-cells in diabetes using biased and unbiased approaches”

Albert Lecture Theatre, 4pm, Tuesday 28th of October 2014.

James D. Johnson, Ph.D.

Oxford University Visiting Professor of Integrated Physiology, OCDEM/WTCHG,Visiting Fellow of Harris-Manchester College Associate Professor | Medicine |
Cellular and Physiological Sciences, Surgery Diabetes Research Group, Cardiovascular Research Group The University of British Columbia| Canada

Jim Johnson is Associate Professor in the
Department of Cellular and Physiological Sciences and Department of Surgery at
the University of British Columbia. He is a founding member of the Diabetes
Research Group at the Life Sciences Institute at UBC. He is Editor-in-Chief of
the journal Islets, and on the Editorial Board of Diabetes and Endocrinology.
An expert in the fundamental biology of diabetes and related conditions, he is
the author of over 93 peer-reviewed articles since 2000. His work has been
published in some of the most prestigious and highly cited journals including Cell
Metabolism, Diabetes, Diabetologia, Endocrinology, PNAS, Nature Medicine

 His current research focuses on multiple
themes, including: type 1 diabetes, type 2 diabetes, obesity, heart disease,
neuroscience, pancreatic cancer, and longevity. He teaches human physiology to
large and small classes and directly mentors ~12 students and 5 post-doctoral
fellows in his laboratory. The work of his team involves a multidisciplinary
approach. His work has been funded by the JDRF, the Canadian Institutes of
Health Research, the Canadian Diabetes Association, the Stem Cell Network, the
Cancer Research Society, the Canada Foundation for Innovation, and other agencies.

We are delighted to welcome Prof. Johnson to RCSI and the Centre for Systems
Medicine and all very welcome to attend,

Prof.  Jochen Prehn

Exploiting addiction to apoptosis inhibitors in cancer

 Exploiting addiction to apoptosis inhibitors in cancer

Speaker: Dr Daniel Longley, Centre for Cancer Research and Cell Biology, Queen’s University Belfast
Monday 6th October 2014, at 4.00 pm

Dear Colleagues,

The Centre for Systems Medicine is pleased to announce another speaker of our seminar series, Dr Daniel Longley.

Dr Longley’s research is focussed on overcoming drug resistance by activating cell death (apoptosis) in cancer cells. Specifically, his research is centred on the
pre-clinical and clinical development of small molecule inhibitors of
anti-apoptotic proteins, including novel drug delivery strategies, and the
identification of predictive biomarkers to enable the targeted use of novel
anti-cancer therapeutics in molecularly-defined patient populations.


The talk will be held in the Cheyne Lecture Theatre at 4.00pm 6th October 2014.

You are all very welcome to attend.


Markus Rehm

Centre for Systems Medicine